The contribution of kinetoplast DNA to Leishmania major experimental infection and evaluation of Leishmania extracellular vesicle based vaccine against cutaneous Leishmaniasis in BALB/C mice

2019
Ayanoğlu, İhsan Cihan
Cutaneous Leishmaniasis (CL) is a neglected vector borne parasitic infection that manifests as self-healing skin lesions or cause debilitating large chronic or recurring lesions. CL is endemic in Turkey and its incidence rate is on the rise due to immigration of refugees from affected regions. Leishmania parasites harbor a unique mitochondrial DNA structure called kinetoplast DNA (kDNA), consisting of giant networks of catenated mini and maxi-circles. The role of kDNA in infection is poorly understood. In the first part of this thesis, we evaluated the possible contribution of kDNA to Leishmania major experimental infection. Herein we show that stimulation of immune cells with kDNA increases the parasite load in vitro and exacerbates disease progression in L.major induced BALB/c model of CL. Our results suggest that kDNA may have a role in facilitating parasite evasion from the immune system through induction of type-I interferon signaling pathways. The absence of an available licensed vaccine coupled with the cost, toxicity and drug resistance associated with drugs used for treatment, necessitates the development of an effective preventive vaccine. In the second part of this thesis, we explored the immunoprotective and immunotherapeutic potential of Leishmania antigen-rich extracellular vesicles (exosomes) in combination with CpG ODN, cGAMP or glycolipid based (αGalCER) vaccine adjuvants. Our results demonstrated that chemically inactivated L.major exosomes exhibited immunotherapeutic effects when combined with D-ODN, resulting in reduction in parasite loads in infected BALB/c mice. Vaccination studies revealed that exosomes adjuvanted with αGalCER provided immunoprotection in L.major induced BALB/c model of CL.

Suggestions

Development of recombinant vaccines composed of PlpE and OmpH from pasteurella multocida A:3
Okay, Sezer; Özcengiz, Gülay; Department of Biology (2011)
Pasteurella multocida serotype A:3 is a gram-negative bacterial pathogen which is one of the causative agents of shipping fever in cattle. In this study, ompH and two fragments of plpE gene (plpEN and plpEC) were cloned from the genomic DNA of P. multocida P-1062 (ATCC 15743, serotype A:3) and plpEN-ompH and plpEC-ompH fusions were constructed. In vitro expression of the genes was shown in HEK-293 cells. Later, full-length plpE gene was cloned and the recombinant proteins were expressed in E. coli and purif...
The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases
Sahin, Ozlem; Ziaei, Alireza; Karaismailoğlu, Eda; Taheri, Nusret (Springer Science and Business Media LLC, 2016-2-16)
Background: Increased serum levels of angiotensin converting enzyme and lysozyme are considered as inflammatory markers for diagnosis of sarcoidosis which is an autoimmune inflammatory disease. The purpose of this study is to evaluate the significance of differences in serum angiotensin converting enzyme and lysozyme levels of patients with ocular involvement of other autoimmune inflammatory and infectious diseases. Methods: This is a prospective study involving patients with ankylosing spondylitis, behc...
Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice
Okay, Sezer; Ozcengiz, Erkan; GÜRSEL, İHSAN; Özcengiz, Gülay (2012-12-01)
Pasteurella multocida serotype A:3 is a Gram-negative bacterial pathogen, one of the causative agents of shipping fever of cattle. In this study, outer membrane protein H (ompH) and Pasteurella lipoprotein E (plpE) genes were cloned and plpEC-ompH fusion was constructed and expressed in Escherichia coli. Recombinant PlpE, OmpH and PlpEC-OmpH fusion proteins were purified and formulated with oil-based and oil-based CpG ODN adjuvants. Antibody responses in mice vaccinated with recombinant PlpE and PlpEC-OmpH ...
Ultra-fast quantitation of voriconazole in human plasma by coated blade spray mass spectrometry
Tascon, Marcos; Gomez-Rios, German Augusto; Reyes-Garces, Nathaly; Poole, Justen; Boyacı, Ezel; Pawliszyn, Janusz (2017-09-10)
Voriconazole is a triazole broad-spectrum antifungal medication often used to treat fungal infections caused by Aspergillus and Fusarium species. One of the main challenges associated with the implementation of this medication is its narrow therapeutic concentration range, demonstrating toxicity at concentrations above 6 mu g/mL and limited efficacy at concentrations below 2 mu g/mL. As a result, methodologies which permit the rapid and accurate quantitation of voriconazole in patients are highly desirable....
In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes
Erdemli, Ozge; Özen, Seza; Keskin, Dilek; Usanmaz, Ali; Batu, Ezgi Deniz; Atilla, Bülent; Tezcaner, Ayşen (2014-10-01)
Anti-tumor necrosis factor (TNF) drugs such as etanercept (ETN) have been mostly used in systemic treatment of rheumatoid arthritis. To eliminate the side effects in long-term treatments and to achieve a local sustained anti-inflammatory effect, a controlled drug delivery system is needed for anti-TNF drugs. This study aims to develop novel injectable microcarriers of ETN that can provide long-term controlled release of this protein drug upon intra-articular application. In this study, poly(epsilon-caprolac...
Citation Formats
İ. C. Ayanoğlu, “The contribution of kinetoplast DNA to Leishmania major experimental infection and evaluation of Leishmania extracellular vesicle based vaccine against cutaneous Leishmaniasis in BALB/C mice,” Thesis (Ph.D.) -- Graduate School of Natural and Applied Sciences. Biology., Middle East Technical University, 2019.